+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sacubitril Valsartan Sodium Tablets Market - Global Forecast 2026-2032- Product Image
Sacubitril Valsartan Sodium Tablets Market - Global Forecast 2026-2032- Product Image
Sale

Sacubitril Valsartan Sodium Tablets Market - Global Forecast 2026-2032

  • Report

  • 181 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6079763
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Sacubitril Valsartan Sodium Tablets Market is projected to reach USD 10.98 Billion in 2026. It is expected to continue growing at a CAGR of 7.78%, reaching USD 17.28 Billion by 2032.

Sacubitril Valsartan Sodium Tablets: Executive Overview

Sacubitril valsartan sodium tablets combine neprilysin inhibition with angiotensin-receptor blockade and are used primarily in guideline-directed treatment of selected patients with heart failure with reduced ejection fraction. Their clinical role is shaped by evidence on reduced cardiovascular mortality and hospitalization, prescribing guidance, tolerability, access, and the need for appropriate patient selection and monitoring. This summary focuses on documented therapeutic, regulatory, regional, and health-system considerations without presenting market estimates or company-specific claims.

Guideline Integration and Access Are Reshaping Use

Use of sacubitril valsartan has increasingly been integrated into contemporary heart-failure treatment pathways alongside beta blockers, mineralocorticoid-receptor antagonists, and sodium-glucose cotransporter-2 inhibitors. Important practical considerations include blood-pressure tolerance, renal function, potassium levels, prior angiotensin-converting-enzyme inhibitor exposure, contraindications, and the required washout period after an angiotensin-converting-enzyme inhibitor. Broader access to generic formulations in some jurisdictions may support affordability, while reimbursement rules, clinical familiarity, and diagnostic capacity continue to influence uptake.

Artificial Intelligence Supports Safer, More Targeted Heart-Failure Care

Artificial intelligence can contribute to earlier identification of patients at risk of heart-failure deterioration through analysis of electronic records, imaging, laboratory data, and remote-monitoring signals. It may also support medication optimization, adherence interventions, adverse-event surveillance, and trial recruitment. However, clinical deployment requires external validation, transparent performance assessment, protection of patient data, and physician oversight. AI should complement-not replace-assessment of blood pressure, renal function, potassium, symptoms, and treatment contraindications when sacubitril valsartan is prescribed.

Regional Insights: Uneven Diagnosis, Treatment Access, and Monitoring Capacity

North America generally benefits from established heart-failure guidelines, specialist infrastructure, and broad access to advanced pharmacotherapy, although affordability and insurance coverage remain relevant barriers. Europe has strong guideline adoption and regulatory capacity, but access and prescribing practices differ across national reimbursement systems. Asia-Pacific combines substantial cardiovascular disease burden with wide variation in diagnosis, clinical infrastructure, and medicine availability. Latin America faces disparities in specialist care, reimbursement, and continuity of treatment. In the Middle East, concentrated tertiary-care capacity coexists with differences in prevention and chronic-disease management. Africa continues to face major gaps in diagnosis, specialist services, essential-medicine availability, and laboratory monitoring, making health-system strengthening particularly important.

Group Insights: Policy Blocs Differ in Health-System Readiness

ASEAN markets show varied regulatory systems, reimbursement structures, and healthcare capacity, requiring locally adapted access and education strategies. BRICS members span diverse disease burdens and health-system models, with affordability, domestic supply, and rural access especially important. The European Union benefits from shared scientific and regulatory frameworks, while national pricing and reimbursement decisions remain decisive. G7 countries generally possess mature clinical infrastructure and data systems but continue to address affordability and aging-related heart-failure demand. GCC states often have relatively strong tertiary-care capacity, alongside opportunities to improve prevention and long-term adherence. NATO members are not a uniform healthcare bloc, yet many share interest in resilient pharmaceutical supply chains and continuity of care during disruptions.

Country Insights: Local Guidelines and Reimbursement Shape Adoption

Australia, Canada, France, Germany, Italy, Japan, Spain, the United Kingdom, and the United States have established cardiovascular-care systems, but national guidelines, formularies, prescribing pathways, and patient cost exposure differ. China and India combine large patient populations with substantial variation between urban and rural care, making primary-care capability and affordability central issues. Brazil and Mexico face regional disparities in specialist access and public-sector medicine availability. Russia’s treatment environment is influenced by domestic procurement, regulatory policy, and uneven access across regions. South Korea has advanced hospital infrastructure, while age-related heart-failure management and reimbursement criteria remain important considerations. Across all listed countries, renal and potassium monitoring, transition from hospital to outpatient care, and adherence support are practical priorities.

Priorities for Leaders: Improve Appropriate Use and Continuity of Care

Industry leaders should align evidence generation with current heart-failure guidelines and clearly define patient-selection, dosing, contraindication, and monitoring requirements. Access strategies should account for public and private reimbursement, generic competition where applicable, supply continuity, and affordability for chronic therapy. Partnerships with clinicians and health systems can strengthen early diagnosis, discharge planning, medication titration, and adherence. Digital tools, including validated AI applications, should be introduced with governance, bias monitoring, cybersecurity controls, and measurable clinical outcomes. Local education and post-market safety surveillance are essential, particularly where primary-care capacity and laboratory access are limited.

Research Methodology: Evidence-Led Review of Clinical and Health-System Factors

This executive summary uses the defined market scope-sacubitril valsartan sodium tablets-and synthesizes verified public evidence from clinical guidelines, regulatory information, peer-reviewed cardiovascular research, and documented health-system and access considerations. The analysis compares implications across the required regions, country groups, and countries while avoiding market estimates, forecasts, shares, and company-specific discussion. Findings are framed as qualitative insights, with emphasis on therapeutic positioning, safety monitoring, reimbursement, infrastructure, and implementation conditions. Interpretation should be updated as guidelines, regulatory decisions, evidence, and national policies change.

Conclusion: Clinical Value Depends on Appropriate, Equitable Implementation

Sacubitril valsartan sodium tablets occupy an important place in contemporary management of selected heart-failure patients, but their real-world benefit depends on accurate diagnosis, guideline-concordant initiation, titration, monitoring, and sustained adherence. Regional and national differences in reimbursement, healthcare capacity, and medicine access will continue to shape use. Leaders can improve outcomes by combining evidence-based clinical education, resilient supply and access programs, responsible digital innovation, and coordinated follow-up across hospital and community care.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Sacubitril Valsartan Sodium Tablets Market, by Product Type
7.1. Introduction
7.2. Branded
7.3. Generic
8. Sacubitril Valsartan Sodium Tablets Market, by Strength
8.1. Introduction
8.2. 24/26 mg
8.3. 49/51 mg
8.4. 97/103 mg
9. Sacubitril Valsartan Sodium Tablets Market, by Dosage Form
9.1. Introduction
9.2. Film-Coated Tablet
9.3. Tablet
10. Sacubitril Valsartan Sodium Tablets Market, by Distribution Channel
10.1. Introduction
10.2. Offline
10.3. Online
11. Sacubitril Valsartan Sodium Tablets Market, by End-User
11.1. Introduction
11.2. Clinic
11.3. Home Care
11.4. Hospital
12. Sacubitril Valsartan Sodium Tablets Market, by Region
12.1. Introduction
12.2. Asia-Pacific
12.3. North America
12.4. Latin America
12.5. Europe
12.6. Middle East
12.7. Africa
13. Sacubitril Valsartan Sodium Tablets Market, by Group
13.1. Introduction
13.2. ASEAN
13.3. GCC
13.4. European Union
13.5. BRICS
13.6. G7
13.7. NATO
14. Sacubitril Valsartan Sodium Tablets Market, by Country
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. United Kingdom
14.7. Germany
14.8. France
14.9. Russia
14.10. Italy
14.11. Spain
14.12. China
14.13. India
14.14. Japan
14.15. Australia
14.16. South Korea
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. Market Concentration Analysis, 2025
15.2.1. Concentration Ratio (CR)
15.2.2. Herfindahl Hirschman Index (HHI)
15.3. Recent Developments & Impact Analysis, 2025
15.4. Product Portfolio Analysis, 2025
15.5. Benchmarking Analysis, 2025
16. Company Profiles
16.1. Aspen Pharmacare Holdings Limited
16.2. Aurobindo Pharma Limited
16.3. Cipla Limited
16.4. Dr. Reddy's Laboratories Ltd.
16.5. Glenmark Pharmaceuticals Ltd.
16.6. Hetero Labs Limited
16.7. Lupin Limited
16.8. MacLeod's Pharmaceuticals Ltd.
16.9. MSN Laboratories Private Limited
16.10. Mylan N.V.
16.11. Natco Pharma Limited
16.12. Novartis AG
16.13. Orion Corporation
16.14. Pfizer Inc.
16.15. Sandoz International GmbH
16.16. Sun Pharmaceutical Industries Ltd.
16.17. Teva Pharmaceutical Industries Ltd.
16.18. Torrent Pharmaceuticals Ltd.
16.19. Zydus Lifesciences Limited
17. Key Experts
LIST OF FIGURES
FIGURE 1. Global Sacubitril Valsartan Sodium Tablets Market, Years Considered for the Study
FIGURE 2. Global Sacubitril Valsartan Sodium Tablets Market, Research Design
FIGURE 3. Global Sacubitril Valsartan Sodium Tablets Market, Research Framework
FIGURE 4. Global Sacubitril Valsartan Sodium Tablets Market, Data Triangulation
FIGURE 5. Global Sacubitril Valsartan Sodium Tablets Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Sacubitril Valsartan Sodium Tablets Market Size, by Product Type, 2025 vs 2032 (%)
FIGURE 7. Global Sacubitril Valsartan Sodium Tablets Market Size, by Product Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Sacubitril Valsartan Sodium Tablets Market Size, by Strength, 2025 vs 2032 (%)
FIGURE 9. Global Sacubitril Valsartan Sodium Tablets Market Size, by Strength, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Sacubitril Valsartan Sodium Tablets Market Size, by Dosage Form, 2025 vs 2032 (%)
FIGURE 11. Global Sacubitril Valsartan Sodium Tablets Market Size, by Dosage Form, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Sacubitril Valsartan Sodium Tablets Market Size, by Distribution Channel, 2025 vs 2032 (%)
FIGURE 13. Global Sacubitril Valsartan Sodium Tablets Market Size, by Distribution Channel, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Sacubitril Valsartan Sodium Tablets Market Size, by End-User, 2025 vs 2032 (%)
FIGURE 15. Global Sacubitril Valsartan Sodium Tablets Market Size, by End-User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Sacubitril Valsartan Sodium Tablets Market Size, by Region, 2025 vs 2032 (%)
FIGURE 17. Global Sacubitril Valsartan Sodium Tablets Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Sacubitril Valsartan Sodium Tablets Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Sacubitril Valsartan Sodium Tablets Market Size, by Country, 2025 vs 2032 (%)
FIGURE 20. Global Sacubitril Valsartan Sodium Tablets Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Sacubitril Valsartan Sodium Tablets Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Sacubitril Valsartan Sodium Tablets Market Segmentation & Coverage
TABLE 2. Global Sacubitril Valsartan Sodium Tablets Market Size, 2017-2032 (USD Million)
TABLE 3. Global Sacubitril Valsartan Sodium Tablets Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 4. Global Branded Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Branded Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Branded Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Generic Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Generic Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Generic Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Sacubitril Valsartan Sodium Tablets Market Size, by Strength, 2017-2032 (USD Million)
TABLE 11. Global 24/26 mg Market Size, by Region, 2017-2032 (USD Million)
TABLE 12. Global 24/26 mg Market Size, by Group, 2017-2032 (USD Million)
TABLE 13. Global 24/26 mg Market Size, by Country, 2017-2032 (USD Million)
TABLE 14. Global 49/51 mg Market Size, by Region, 2017-2032 (USD Million)
TABLE 15. Global 49/51 mg Market Size, by Group, 2017-2032 (USD Million)
TABLE 16. Global 49/51 mg Market Size, by Country, 2017-2032 (USD Million)
TABLE 17. Global 97/103 mg Market Size, by Region, 2017-2032 (USD Million)
TABLE 18. Global 97/103 mg Market Size, by Group, 2017-2032 (USD Million)
TABLE 19. Global 97/103 mg Market Size, by Country, 2017-2032 (USD Million)
TABLE 20. Global Sacubitril Valsartan Sodium Tablets Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 21. Global Film-Coated Tablet Market Size, by Region, 2017-2032 (USD Million)
TABLE 22. Global Film-Coated Tablet Market Size, by Group, 2017-2032 (USD Million)
TABLE 23. Global Film-Coated Tablet Market Size, by Country, 2017-2032 (USD Million)
TABLE 24. Global Tablet Market Size, by Region, 2017-2032 (USD Million)
TABLE 25. Global Tablet Market Size, by Group, 2017-2032 (USD Million)
TABLE 26. Global Tablet Market Size, by Country, 2017-2032 (USD Million)
TABLE 27. Global Sacubitril Valsartan Sodium Tablets Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 28. Global Offline Market Size, by Region, 2017-2032 (USD Million)
TABLE 29. Global Offline Market Size, by Group, 2017-2032 (USD Million)
TABLE 30. Global Offline Market Size, by Country, 2017-2032 (USD Million)
TABLE 31. Global Online Market Size, by Region, 2017-2032 (USD Million)
TABLE 32. Global Online Market Size, by Group, 2017-2032 (USD Million)
TABLE 33. Global Online Market Size, by Country, 2017-2032 (USD Million)
TABLE 34. Global Sacubitril Valsartan Sodium Tablets Market Size, by End-User, 2017-2032 (USD Million)
TABLE 35. Global Clinic Market Size, by Region, 2017-2032 (USD Million)
TABLE 36. Global Clinic Market Size, by Group, 2017-2032 (USD Million)
TABLE 37. Global Clinic Market Size, by Country, 2017-2032 (USD Million)
TABLE 38. Global Home Care Market Size, by Region, 2017-2032 (USD Million)
TABLE 39. Global Home Care Market Size, by Group, 2017-2032 (USD Million)
TABLE 40. Global Home Care Market Size, by Country, 2017-2032 (USD Million)
TABLE 41. Global Hospital Market Size, by Region, 2017-2032 (USD Million)
TABLE 42. Global Hospital Market Size, by Group, 2017-2032 (USD Million)
TABLE 43. Global Hospital Market Size, by Country, 2017-2032 (USD Million)
TABLE 44. Global Sacubitril Valsartan Sodium Tablets Market Size, by Region, 2017-2032 (USD Million)
TABLE 45. Asia-Pacific Sacubitril Valsartan Sodium Tablets Market Size, by Region, 2017-2032 (USD Million)
TABLE 46. Asia-Pacific Sacubitril Valsartan Sodium Tablets Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 47. Asia-Pacific Sacubitril Valsartan Sodium Tablets Market Size, by Strength, 2017-2032 (USD Million)
TABLE 48. Asia-Pacific Sacubitril Valsartan Sodium Tablets Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 49. Asia-Pacific Sacubitril Valsartan Sodium Tablets Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 50. Asia-Pacific Sacubitril Valsartan Sodium Tablets Market Size, by End-User, 2017-2032 (USD Million)
TABLE 51. North America Sacubitril Valsartan Sodium Tablets Market Size, by Region, 2017-2032 (USD Million)
TABLE 52. North America Sacubitril Valsartan Sodium Tablets Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 53. North America Sacubitril Valsartan Sodium Tablets Market Size, by Strength, 2017-2032 (USD Million)
TABLE 54. North America Sacubitril Valsartan Sodium Tablets Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 55. North America Sacubitril Valsartan Sodium Tablets Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 56. North America Sacubitril Valsartan Sodium Tablets Market Size, by End-User, 2017-2032 (USD Million)
TABLE 57. Latin America Sacubitril Valsartan Sodium Tablets Market Size, by Region, 2017-2032 (USD Million)
TABLE 58. Latin America Sacubitril Valsartan Sodium Tablets Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 59. Latin America Sacubitril Valsartan Sodium Tablets Market Size, by Strength, 2017-2032 (USD Million)
TABLE 60. Latin America Sacubitril Valsartan Sodium Tablets Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 61. Latin America Sacubitril Valsartan Sodium Tablets Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 62. Latin America Sacubitril Valsartan Sodium Tablets Market Size, by End-User, 2017-2032 (USD Million)
TABLE 63. Europe Sacubitril Valsartan Sodium Tablets Market Size, by Region, 2017-2032 (USD Million)
TABLE 64. Europe Sacubitril Valsartan Sodium Tablets Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 65. Europe Sacubitril Valsartan Sodium Tablets Market Size, by Strength, 2017-2032 (USD Million)
TABLE 66. Europe Sacubitril Valsartan Sodium Tablets Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 67. Europe Sacubitril Valsartan Sodium Tablets Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 68. Europe Sacubitril Valsartan Sodium Tablets Market Size, by End-User, 2017-2032 (USD Million)
TABLE 69. Middle East Sacubitril Valsartan Sodium Tablets Market Size, by Region, 2017-2032 (USD Million)
TABLE 70. Middle East Sacubitril Valsartan Sodium Tablets Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 71. Middle East Sacubitril Valsartan Sodium Tablets Market Size, by Strength, 2017-2032 (USD Million)
TABLE 72. Middle East Sacubitril Valsartan Sodium Tablets Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 73. Middle East Sacubitril Valsartan Sodium Tablets Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 74. Middle East Sacubitril Valsartan Sodium Tablets Market Size, by End-User, 2017-2032 (USD Million)
TABLE 75. Africa Sacubitril Valsartan Sodium Tablets Market Size, by Region, 2017-2032 (USD Million)
TABLE 76. Africa Sacubitril Valsartan Sodium Tablets Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 77. Africa Sacubitril Valsartan Sodium Tablets Market Size, by Strength, 2017-2032 (USD Million)
TABLE 78. Africa Sacubitril Valsartan Sodium Tablets Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 79. Africa Sacubitril Valsartan Sodium Tablets Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 80. Africa Sacubitril Valsartan Sodium Tablets Market Size, by End-User, 2017-2032 (USD Million)
TABLE 81. Global Sacubitril Valsartan Sodium Tablets Market Size, by Group, 2017-2032 (USD Million)
TABLE 82. ASEAN Sacubitril Valsartan Sodium Tablets Market Size, by Group, 2017-2032 (USD Million)
TABLE 83. ASEAN Sacubitril Valsartan Sodium Tablets Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 84. ASEAN Sacubitril Valsartan Sodium Tablets Market Size, by Strength, 2017-2032 (USD Million)
TABLE 85. ASEAN Sacubitril Valsartan Sodium Tablets Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 86. ASEAN Sacubitril Valsartan Sodium Tablets Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 87. ASEAN Sacubitril Valsartan Sodium Tablets Market Size, by End-User, 2017-2032 (USD Million)
TABLE 88. GCC Sacubitril Valsartan Sodium Tablets Market Size, by Group, 2017-2032 (USD Million)
TABLE 89. GCC Sacubitril Valsartan Sodium Tablets Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 90. GCC Sacubitril Valsartan Sodium Tablets Market Size, by Strength, 2017-2032 (USD Million)
TABLE 91. GCC Sacubitril Valsartan Sodium Tablets Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 92. GCC Sacubitril Valsartan Sodium Tablets Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 93. GCC Sacubitril Valsartan Sodium Tablets Market Size, by End-User, 2017-2032 (USD Million)
TABLE 94. European Union Sacubitril Valsartan Sodium Tablets Market Size, by Group, 2017-2032 (USD Million)
TABLE 95. European Union Sacubitril Valsartan Sodium Tablets Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 96. European Union Sacubitril Valsartan Sodium Tablets Market Size, by Strength, 2017-2032 (USD Million)
TABLE 97. European Union Sacubitril Valsartan Sodium Tablets Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 98. European Union Sacubitril Valsartan Sodium Tablets Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 99. European Union Sacubitril Valsartan Sodium Tablets Market Size, by End-User, 2017-2032 (USD Million)
TABLE 100. BRICS Sacubitril Valsartan Sodium Tablets Market Size, by Group, 2017-2032 (USD Million)
TABLE 101. BRICS Sacubitril Valsartan Sodium Tablets Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 102. BRICS Sacubitril Valsartan Sodium Tablets Market Size, by Strength, 2017-2032 (USD Million)
TABLE 103. BRICS Sacubitril Valsartan Sodium Tablets Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 104. BRICS Sacubitril Valsartan Sodium Tablets Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 105. BRICS Sacubitril Valsartan Sodium Tablets Market Size, by End-User, 2017-2032 (USD Million)
TABLE 106. G7 Sacubitril Valsartan Sodium Tablets Market Size, by Group, 2017-2032 (USD Million)
TABLE 107. G7 Sacubitril Valsartan Sodium Tablets Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 108. G7 Sacubitril Valsartan Sodium Tablets Market Size, by Strength, 2017-2032 (USD Million)
TABLE 109. G7 Sacubitril Valsartan Sodium Tablets Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 110. G7 Sacubitril Valsartan Sodium Tablets Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 111. G7 Sacubitril Valsartan Sodium Tablets Market Size, by End-User, 2017-2032 (USD Million)
TABLE 112. NATO Sacubitril Valsartan Sodium Tablets Market Size, by Group, 2017-2032 (USD Million)
TABLE 113. NATO Sacubitril Valsartan Sodium Tablets Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 114. NATO Sacubitril Valsartan Sodium Tablets Market Size, by Strength, 2017-2032 (USD Million)
TABLE 115. NATO Sacubitril Valsartan Sodium Tablets Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 116. NATO Sacubitril Valsartan Sodium Tablets Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 117. NATO Sacubitril Valsartan Sodium Tablets Market Size, by End-User, 2017-2032 (USD Million)
TABLE 118. Global Sacubitril Valsartan Sodium Tablets Market Size, by Country, 2017-2032 (USD Million)
TABLE 119. United States Sacubitril Valsartan Sodium Tablets Market Size, 2017-2032 (USD Million)
TABLE 120. United States Sacubitril Valsartan Sodium Tablets Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 121. United States Sacubitril Valsartan Sodium Tablets Market Size, by Strength, 2017-2032 (USD Million)
TABLE 122. United States Sacubitril Valsartan Sodium Tablets Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 123. United States Sacubitril Valsartan Sodium Tablets Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 124. United States Sacubitril Valsartan Sodium Tablets Market Size, by End-User, 2017-2032 (USD Million)
TABLE 125. Canada Sacubitril Valsartan Sodium Tablets Market Size, 2017-2032 (USD Million)
TABLE 126. Canada Sacubitril Valsartan Sodium Tablets Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 127. Canada Sacubitril Valsartan Sodium Tablets Market Size, by Strength, 2017-2032 (USD Million)
TABLE 128. Canada Sacubitril Valsartan Sodium Tablets Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 129. Canada Sacubitril Valsartan Sodium Tablets Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 130. Canada Sacubitril Valsartan Sodium Tablets Market Size, by End-User, 2017-2032 (USD Million)
TABLE 131. Mexico Sacubitril Valsartan Sodium Tablets Market Size, 2017-2032 (USD Million)
TABLE 132. Mexico Sacubitril Valsartan Sodium Tablets Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 133. Mexico Sacubitril Valsartan Sodium Tablets Market Size, by Strength, 2017-2032 (USD Million)
TABLE 134. Mexico Sacubitril Valsartan Sodium Tablets Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 135. Mexico Sacubitril Valsartan Sodium Tablets Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 136. Mexico Sacubitril Valsartan Sodium Tablets Market Size, by End-User, 2017-2032 (USD Million)
TABLE 137. Brazil Sacubitril Valsartan Sodium Tablets Market Size, 2017-2032 (USD Million)
TABLE 138. Brazil Sacubitril Valsartan Sodium Tablets Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 139. Brazil Sacubitril Valsartan Sodium Tablets Market Size, by Strength, 2017-2032 (USD Million)
TABLE 140. Brazil Sacubitril Valsartan Sodium Tablets Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 141. Brazil Sacubitril Valsartan Sodium Tablets Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 142. Brazil Sacubitril Valsartan Sodium Tablets Market Size, by End-User, 2017-2032 (USD Million)
TABLE 143. United Kingdom Sacubitril Valsartan Sodium Tablets Market Size, 2017-2032 (USD Million)
TABLE 144. United Kingdom Sacubitril Valsartan Sodium Tablets Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 145. United Kingdom Sacubitril Valsartan Sodium Tablets Market Size, by Strength, 2017-2032 (USD Million)
TABLE 146. United Kingdom Sacubitril Valsartan Sodium Tablets Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 147. United Kingdom Sacubitril Valsartan Sodium Tablets Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 148. United Kingdom Sacubitril Valsartan Sodium Tablets Market Size, by End-User, 2017-2032 (USD Million)
TABLE 149. Germany Sacubitril Valsartan Sodium Tablets Market Size, 2017-2032 (USD Million)
TABLE 150. Germany Sacubitril Valsartan Sodium Tablets Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 151. Germany Sacubitril Valsartan Sodium Tablets Market Size, by Strength, 2017-2032 (USD Million)
TABLE 152. Germany Sacubitril Valsartan Sodium Tablets Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 153. Germany Sacubitril Valsartan Sodium Tablets Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 154. Germany Sacubitril Valsartan Sodium Tablets Market Size, by End-User, 2017-2032 (USD Million)
TABLE 155. France Sacubitril Valsartan Sodium Tablets Market Size, 2017-2032 (USD Million)
TABLE 156. France Sacubitril Valsartan Sodium Tablets Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 157. France Sacubitril Valsartan Sodium Tablets Market Size, by Strength, 2017-2032 (USD Million)
TABLE 158. France Sacubitril Valsartan Sodium Tablets Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 159. France Sacubitril Valsartan Sodium Tablets Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 160. France Sacubitril Valsartan Sodium Tablets Market Size, by End-User, 2017-2032 (USD Million)
TABLE 161. Russia Sacubitril Valsartan Sodium Tablets Market Size, 2017-2032 (USD Million)
TABLE 162. Russia Sacubitril Valsartan Sodium Tablets Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 163. Russia Sacubitril Valsartan Sodium Tablets Market Size, by Strength, 2017-2032 (USD Million)
TABLE 164. Russia Sacubitril Valsartan Sodium Tablets Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 165. Russia Sacubitril Valsartan Sodium Tablets Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 166. Russia Sacubitril Valsartan Sodium Tablets Market Size, by End-User, 2017-2032 (USD Million)
TABLE 167. Italy Sacubitril Valsartan Sodium Tablets Market Size, 2017-2032 (USD Million)
TABLE 168. Italy Sacubitril Valsartan Sodium Tablets Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 169. Italy Sacubitril Valsartan Sodium Tablets Market Size, by Strength, 2017-2032 (USD Million)
TABLE 170. Italy Sacubitril Valsartan Sodium Tablets Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 171. Italy Sacubitril Valsartan Sodium Tablets Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 172. Italy Sacubitril Valsartan Sodium Tablets Market Size, by End-User, 2017-2032 (USD Million)
TABLE 173. Spain Sacubitril Valsartan Sodium Tablets Market Size, 2017-2032 (USD Million)
TABLE 174. Spain Sacubitril Valsartan Sodium Tablets Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 175. Spain Sacubitril Valsartan Sodium Tablets Market Size, by Strength, 2017-2032 (USD Million)
TABLE 176. Spain Sacubitril Valsartan Sodium Tablets Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 177. Spain Sacubitril Valsartan Sodium Tablets Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 178. Spain Sacubitril Valsartan Sodium Tablets Market Size, by End-User, 2017-2032 (USD Million)
TABLE 179. China Sacubitril Valsartan Sodium Tablets Market Size, 2017-2032 (USD Million)
TABLE 180. China Sacubitril Valsartan Sodium Tablets Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 181. China Sacubitril Valsartan Sodium Tablets Market Size, by Strength, 2017-2032 (USD Million)
TABLE 182. China Sacubitril Valsartan Sodium Tablets Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 183. China Sacubitril Valsartan Sodium Tablets Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 184. China Sacubitril Valsartan Sodium Tablets Market Size, by End-User, 2017-2032 (USD Million)
TABLE 185. India Sacubitril Valsartan Sodium Tablets Market Size, 2017-2032 (USD Million)
TABLE 186. India Sacubitril Valsartan Sodium Tablets Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 187. India Sacubitril Valsartan Sodium Tablets Market Size, by Strength, 2017-2032 (USD Million)
TABLE 188. India Sacubitril Valsartan Sodium Tablets Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 189. India Sacubitril Valsartan Sodium Tablets Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 190. India Sacubitril Valsartan Sodium Tablets Market Size, by End-User, 2017-2032 (USD Million)
TABLE 191. Japan Sacubitril Valsartan Sodium Tablets Market Size, 2017-2032 (USD Million)
TABLE 192. Japan Sacubitril Valsartan Sodium Tablets Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 193. Japan Sacubitril Valsartan Sodium Tablets Market Size, by Strength, 2017-2032 (USD Million)
TABLE 194. Japan Sacubitril Valsartan Sodium Tablets Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 195. Japan Sacubitril Valsartan Sodium Tablets Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 196. Japan Sacubitril Valsartan Sodium Tablets Market Size, by End-User, 2017-2032 (USD Million)
TABLE 197. Australia Sacubitril Valsartan Sodium Tablets Market Size, 2017-2032 (USD Million)
TABLE 198. Australia Sacubitril Valsartan Sodium Tablets Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 199. Australia Sacubitril Valsartan Sodium Tablets Market Size, by Strength, 2017-2032 (USD Million)
TABLE 200. Australia Sacubitril Valsartan Sodium Tablets Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 201. Australia Sacubitril Valsartan Sodium Tablets Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 202. Australia Sacubitril Valsartan Sodium Tablets Market Size, by End-User, 2017-2032 (USD Million)
TABLE 203. South Korea Sacubitril Valsartan Sodium Tablets Market Size, 2017-2032 (USD Million)
TABLE 204. South Korea Sacubitril Valsartan Sodium Tablets Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 205. South Korea Sacubitril Valsartan Sodium Tablets Market Size, by Strength, 2017-2032 (USD Million)
TABLE 206. South Korea Sacubitril Valsartan Sodium Tablets Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 207. South Korea Sacubitril Valsartan Sodium Tablets Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 208. South Korea Sacubitril Valsartan Sodium Tablets Market Size, by End-User, 2017-2032 (USD Million)
TABLE 209. Global Sacubitril Valsartan Sodium Tablets Market Share, by Key Player, 2025
TABLE 210. Global Sacubitril Valsartan Sodium Tablets Market, Key Experts

Companies Mentioned

  • Aspen Pharmacare Holdings Limited
  • Aurobindo Pharma Limited
  • Cipla Limited
  • Dr. Reddy's Laboratories Ltd.
  • Glenmark Pharmaceuticals Ltd.
  • Hetero Labs Limited
  • Lupin Limited
  • MacLeod's Pharmaceuticals Ltd.
  • MSN Laboratories Private Limited
  • Mylan N.V.
  • Natco Pharma Limited
  • Novartis AG
  • Orion Corporation
  • Pfizer Inc.
  • Sandoz International GmbH
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Torrent Pharmaceuticals Ltd.
  • Zydus Lifesciences Limited

Related Topics

Related Reports

Sacubitril Valsartan Sodium Drugs Market - Global Forecast 2026-2032 - Product Image

Sacubitril Valsartan Sodium Drugs Market - Global Forecast 2026-2032

  • Report
  • 189 Pages
  • Global
From
Valsartan Global Market Insights 2025, Analysis and Forecast to 2030, by Manufacturers, Regions, Technology, Product Type - Product Image

Valsartan Global Market Insights 2025, Analysis and Forecast to 2030, by Manufacturers, Regions, Technology, Product Type

  • Report
  • 105 Pages
  • Global
From
Valsartan (CAS 137862-53-4) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029 - Product Image

Valsartan (CAS 137862-53-4) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029

  • Report
  • 50 Pages
  • Global
From
Angiotensin Receptor Blockers (ARBs) Market Report 2026 - Product Image

Angiotensin Receptor Blockers (ARBs) Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Atherosclerosis Drugs - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031) - Product Image

Atherosclerosis Drugs - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • Report
  • 110 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.